Alzheimer Disease and Dementia

Latest News

Alzheimer Drug Cost Drives Increase in Medicare B Premium

Aduhelm, the new and expensive drug for Alzheimer disease, is responsible for about half of the $21.60 increase in monthly premiums for the Medicare Part B outpatient program in 2022.

Mirtazapine Does Not Reduce Agitation in Dementia Patients

Among patients with dementia, agitated behaviors are not reduced with mirtazapine versus placebo at 12 weeks.

Methylphenidate Safe and Effective in Reducing Apathy in Alzheimer Disease

By

Brandon May

In a randomized placebo-controlled clinical trial, researchers measured whether methylphenidate, a catecholaminergic compound, compared with placebo decreases the severity of apathy in individuals with Alzheimer disease.

MIND Diet Score Predicts Cognitive Function, Dementia Risk in Older Adults

By

Colby Stong

Researchers sought to examine whether the association of the MIND diet, a mix of the Mediterranean diet and the Dietary Approaches to Stop Hypertension diet, with cognition is independent of common brain pathologies.

Migraine Linked to All-Cause Dementia, Alzheimer Disease

Migraine is associated with an increased risk for all-cause dementia and Alzheimer disease.

Risk for Dementia Not Increased With Menopausal Hormone Therapy

The risk for developing dementia seems not to be increased in association with menopausal hormone therapy.

Physicians Less Likely to Test for Pulmonary Embolism in Dementia Patients

Findings seen in patients with dementia presenting with clinical factors known to be predictive of pulmonary embolism risk

Levetiracetam Well Tolerated for Alzheimer Disease

For patients with Alzheimer disease, levetiracetam is well tolerated and improves performance on certain cognitive tasks among those with epileptiform activity.

Psychosocial Interventions for Patients With Dementia: Here’s What Works

By

Mary Stroka

Performing a systematic review, researchers assessed various psychosocial interventions to determine whether they improve cognitive function and quality of life in patients with moderate to severe dementia.

Ophthalmic Conditions Linked to Increased Risk for Dementia

Age-related macular degeneration, diabetes-related eye disease, and cataract are associated with an increased risk for incident dementia.